Lucia Brodosi
Bologna, BO, 40138, Italy
Location status: Recruiting
NCT Number: NCT06816303
observational study through which we aim to collect information on metabolic compensation, the degree of satisfaction with hypoglycemic therapy, the onset of complications of diabetes or liver disease, evaluation of survival, in patients on the list for at least three months or already undergoing liver transplantation for at least three months
Interested in participating?
Request Info18 year and older
All sexes
Observational
Bologna, BO, 40138, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 5 years
glycometabolic control in relation to therapy
Time frame: through study completion, an average of 5 years
degree of satisfaction with therapy through the administration of Diabetes Treatment Satisfaction Questionnaire (DTSQ)
Contact information is provided by the study sponsor or research team.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Other
Adult Patients With Diabetes Mellitus, on Drug Treatment, on the List or Already Undergoing Orthotopic Liver Transplantation: an Observational Study
Acronym: DiaBoLT2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07622628
Diabetes Mellitus, Diabetes Mellitus Type 2
Izmir, Turkey (Türkiye)
View Trial DetailsNCT06869057
Diabetes Mellitus, Diabetes Mellitus Type 2
Worcester, Massachusetts, United States
View Trial DetailsNCT07011147
Autoimmune Diseases, Diabetes
Aurora, Colorado, United States
View Trial DetailsNCT07129148
Diabetes Complications, Diabetes Mellitus
Changsha, China
View Trial Details